AbbVie 2Q Revenues: $4.9 billion (+5%) 2Q Earnings: $1.1 billion (+3%) YTD Revenues: $9.5 billion (+5%) YTD Earnings: $2.1 billion (+2%) Comments: Humira sales were up 10% to $3.3 billion in the quarter. AndroGel sales reached $218 million. Synthroid ($166 million), Sevoflurane ($154 million, +11%) and Duodopa ($56 million, +29%) also performed well in the quarter. Kaletra sales dropped 24% to $216 million and Lupron sales were down 3% to $186 million. The company recently announced plans t...